ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
BMC Cardiovascular Disorders
◽
10.1186/1471-2261-12-26
◽
2012
◽
Vol 12
(1)
◽
Cited By ~ 10
Author(s):
Torbjørn Wisløff
◽
Randi M Selmer
◽
Sigrun Halvorsen
◽
Atle Fretheim
◽
Ole F Norheim
◽
...
Keyword(s):
Cardiovascular Disease
◽
Cost Effectiveness
◽
Primary Prevention
◽
Antihypertensive Drugs
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
Prevention Of Cardiovascular Disease
Download Full-text
Related Documents
Cited By
References
PCV33 A COST-EFFECTIVENESS ANALYSIS OF LOW-DOSE ASPIRIN IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN FOUR EUROPEAN COUNTRIES
Value in Health
◽
10.1016/s1098-3015(10)67445-1
◽
2005
◽
Vol 8
(6)
◽
pp. A98-A99
Author(s):
M Lamotte
◽
L Annemans
◽
T Evers
◽
M Kubin
Keyword(s):
Cardiovascular Disease
◽
Cost Effectiveness
◽
Primary Prevention
◽
Low Dose
◽
Cost Effectiveness Analysis
◽
European Countries
◽
Dose Aspirin
◽
Effectiveness Analysis
◽
Low Dose Aspirin
◽
Prevention Of Cardiovascular Disease
Download Full-text
PCV20 GENERALIZED COST-EFFECTIVENESS ANALYSIS OF PHARMACEUTICAL INTERVENTIONS FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN THAILAND
Value in Health
◽
10.1016/s1098-3015(11)73147-3
◽
2010
◽
Vol 13
(7)
◽
pp. A520
Author(s):
P Khonputsa
◽
JL Veerman
◽
M Bertram
◽
T Vos
Keyword(s):
Cardiovascular Disease
◽
Cost Effectiveness
◽
Primary Prevention
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
Generalized Cost
◽
Prevention Of Cardiovascular Disease
◽
Pharmaceutical Interventions
Download Full-text
PCV19 THE COST-EFFECTIVENESS ANALYSIS OF ASPIRIN FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE
Value in Health
◽
10.1016/s1098-3015(10)60933-3
◽
2002
◽
Vol 5
(3)
◽
pp. 168-169
Author(s):
PA Patel
◽
J Hay
Keyword(s):
Cardiovascular Disease
◽
Cost Effectiveness
◽
Primary Prevention
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
The Cost
◽
Prevention Of Cardiovascular Disease
Download Full-text
Generalized Cost-Effectiveness Analysis of Pharmaceutical Interventions for Primary Prevention of Cardiovascular Disease in Thailand
Value in Health Regional Issues
◽
10.1016/j.vhri.2012.03.019
◽
2012
◽
Vol 1
(1)
◽
pp. 15-22
◽
Cited By ~ 8
Author(s):
Panrasri Khonputsa
◽
Lennert J. Veerman
◽
Melanie Bertram
◽
Stephen S. Lim
◽
Nathorn Chaiyakunnaphruk
◽
...
Keyword(s):
Cardiovascular Disease
◽
Cost Effectiveness
◽
Primary Prevention
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
Generalized Cost
◽
Prevention Of Cardiovascular Disease
◽
Pharmaceutical Interventions
Download Full-text
Cost-effectiveness analysis of use of a polypill versus usual care or best practice for primary prevention in people at high risk of cardiovascular disease
PLoS ONE
◽
10.1371/journal.pone.0182625
◽
2017
◽
Vol 12
(9)
◽
pp. e0182625
◽
Cited By ~ 7
Author(s):
Sue Jowett
◽
Pelham Barton
◽
Andrea Roalfe
◽
Kate Fletcher
◽
F. D. Richard Hobbs
◽
...
Keyword(s):
Cardiovascular Disease
◽
Cost Effectiveness
◽
Primary Prevention
◽
High Risk
◽
Usual Care
◽
Best Practice
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
Download Full-text
OA07.01. A naturopathic approach to the prevention of cardiovascular disease: a cost effectiveness analysis of a randomized multi-worksite trial
BMC Complementary and Alternative Medicine
◽
10.1186/1472-6882-12-s1-o25
◽
2012
◽
Vol 12
(S1)
◽
Cited By ~ 1
Author(s):
P Herman
◽
O Szczurko
◽
K Cooley
◽
D Seely
Keyword(s):
Cardiovascular Disease
◽
Cost Effectiveness
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
Prevention Of Cardiovascular Disease
Download Full-text
Should health insurers target prevention of cardiovascular disease?: a cost-effectiveness analysis of an individualised programme in Germany based on routine data
BMC Health Services Research
◽
10.1186/1472-6963-14-263
◽
2014
◽
Vol 14
(1)
◽
Cited By ~ 9
Author(s):
Majed Aljutaili
◽
Christian Becker
◽
Sabine Witt
◽
Rolf Holle
◽
Reiner Leidl
◽
...
Keyword(s):
Cardiovascular Disease
◽
Cost Effectiveness
◽
Routine Data
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
Target Prevention
◽
Prevention Of Cardiovascular Disease
◽
Health Insurers
Download Full-text
Cost-effectiveness analysis with defined budget: how to distribute resources for the prevention of cardiovascular disease?
Health Policy
◽
10.1016/s0168-8510(99)00045-7
◽
1999
◽
Vol 48
(3)
◽
pp. 155-170
◽
Cited By ~ 15
Author(s):
Lars Lindholm
◽
C.-G. Hallgren
◽
Kurt Boman
◽
Kenth Markgren
◽
Lars Weinehall
◽
...
Keyword(s):
Cardiovascular Disease
◽
Cost Effectiveness
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
Prevention Of Cardiovascular Disease
Download Full-text
Cost effectiveness analysis of a next generation risk assessment score for cardiovascular disease
Journal of Medical Economics
◽
10.3111/13696998.2013.869500
◽
2013
◽
Vol 17
(2)
◽
pp. 132-141
Author(s):
Evangelos Hytopoulos
◽
Martin L. Lee
◽
Michael Beggs
◽
Cynthia French
◽
Kuo Bianchini Tong
Keyword(s):
Cardiovascular Disease
◽
Risk Assessment
◽
Cost Effectiveness
◽
Cost Effectiveness Analysis
◽
Next Generation
◽
Assessment Score
◽
Effectiveness Analysis
Download Full-text
A Framework for the Cost-Effectiveness Analysis of Novel Biomarker Testing in Cardiovascular Disease
Value in Health
◽
10.1016/j.jval.2017.08.040
◽
2017
◽
Vol 20
(9)
◽
pp. A404-A405
Author(s):
CN Kohli-Lynch
◽
K Boyd
◽
A Briggs
◽
C Delles
Keyword(s):
Cardiovascular Disease
◽
Cost Effectiveness
◽
Cost Effectiveness Analysis
◽
Effectiveness Analysis
◽
Biomarker Testing
◽
The Cost
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close